CLDX Celldex Therapeutics: Forvard P/S multiplikatori
Celldex Therapeutics (CLDX) tadqiqot va ishlanmalar (R&D) xarajatlari tufayli likvidlik yetishmovchiligiga duch kelmoqda, shu bilan birga Anthony Maralucchi yallig'lanish terapiyasi uchun antitanalar ishlab chiqishga resurslarni pragmatik ravishda taqsimlamoqda. Forward P/S koeffitsiyenti masshtablanish premiyasining adekvatligini baholashga yordam beradi, bunda 13951.10 darajasi joriy qiymatlarni aks ettiradi. Ta'minot barqarorligi tashqi pudratchilarga bog'liq bo'lib, bu ushbu grafikdagi narxlar dinamikasi bilan yaqqol isbotlangan.
Celldex Corp (CLDX) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- emitentning balans qiymati statistikasi:
- qarzdorlik darajasi va moliyaviy likvidlik ma'lumotlari:
Qarzning xususiy kapitalga nisbati Celldex Therapeutics|CLDX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Celldex Therapeutics|CLDX - Kompaniyaning jamlangan qarzi|Balans kapitallashuviga qarzlar Celldex Corp|CLDX - Uzoq muddatli qarz|Kompaniyaning qisqa muddatli majburiyatlari Celldex Therapeutics|Tezkor likvidlik ko‘rsatkichi celldex.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
CLDX - Yakuniy foyda|Kelajakdagi foyda Celldex Therapeutics|CLDX - Bozor narxining sof foydaga nisbati|Forvard P/E multiplikatori Celldex|CLDX - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|EV/EBITDA multiplikatori Celldex Corp|CLDX - Foizlar, soliqlar va eskirishdan oldingi foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foyda Celldex Therapeutics|CLDX - Sirpanuvchi yil uchun bir aksiya uchun foyda|Choraklik EPS foyda o'sishi celldex.com|CLDX - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Celldex Therapeutics
- tushum va sotuvlar tafsilotlari:
Kompaniyaning fundamental baholanishi:Celldex Therapeutics, Inc. CLDX
Forward P/S koeffitsiyenti joriy bozor kapitalizatsiyasini prognoz qilingan daromadlar bilan solishtirib, kutilayotgan savdo o'sishi uchun qo'shimcha to'lovni aniqlaydi. Ushbu metrika investorga bozor tebranishlarini filtrlash va aktiv qiymatining uning tijorat salohiyatiga nisbatan adolatli ekanligini baholash imkonini beradi. Kutilayotgan P/S koeffitsiyentini tahlil qilish orqali Celldex Therapeutics (CLDX) aksiyalarini haddan tashqari qimmatga sotib olish xavfini aniqlash mumkin. Kompaniyaning baholanishi barzolvolimab klinik sinovlari natijalari va R&D naqd pullarining sarflanish sur'atiga bog'liqligini hisobga olgan holda, bu juda muhimdir.
Raqobatchilar tahlili
Forvard P/S multiplikatori ARGX (argenx)|BioNTech Inc. (BNTX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Abivax Corp - Forvard P/S multiplikatori|ADMA Corp (ADMA) - Forvard narx/daromad multiplikatori|PTGX: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati immunovant.com (IMVT)|Narxning prognoz qilingan daromadga nisbati Kiniksa|Narxning prognoz qilingan daromadga nisbati GRFS|Narxning prognoz qilingan daromadga nisbati Adaptive Biotechnologies Corp (ADPT)|Narxning prognoz qilingan daromadga nisbati AUPH (Aurinia Corp)|Forvard P/S multiplikatori BCRX (BioCryst)|VERA: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Dianthus Therapeutics, Inc. - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Pharvaris NV|ABCL (AbCellera Biologics Inc) - Forvard narx/daromad multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati TRML|Forvard narx/daromad multiplikatori PGEN|PHAR: Sotuvga nisbatan forvard narx|Forvard narx/daromad multiplikatori NKTR (Nektar Therapeutics Inc.)|Narxning kutilayotgan daromadga nisbati UPB|Forvard P/S multiplikatori ZBIO (Zenas Biopharma, Inc.)|Sotuvga nisbatan forvard narx IMNM|Gossamer Bio, Inc. - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati kalvista.com|Septerna (SEPN) - Narxning prognoz qilingan daromadga nisbati|Pieris Pharma - Sotuvga nisbatan forvard narx|SVRA (Savara Corp) - Forvard P/S multiplikatori|Forvard P/S multiplikatori Rigel Corp|Narxning prognoz qilingan daromadga nisbati AnaptysBio, Inc. (ANAB)|ATXS: Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori ENGN (enGene)|RAPT Therapeutics Inc. (RAPT) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|JBIO: Forvard narx/daromad multiplikatori|ACRS - Forvard P/S multiplikatori|KYTX (Kyverna Therapeutics) - Forvard narx/daromad multiplikatori|TLSA: Narxning kutilayotgan daromadga nisbati|CABA (Cabaletta Bio) - Forvard P/S multiplikatori|Ventyx Biosciences Inc. (VTYX) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard P/S multiplikatori THTX|Forvard narx/daromad multiplikatori Avalo Therapeutics Inc AVTX|Narxning prognoz qilingan daromadga nisbati Eledon Pharmaceuticals ELDN|Kapitalizatsiyaning kutilayotgan sotuvga nisbati agenusbio.com (AGEN)|Climb Bio - Forvard P/S multiplikatori|Zura Bio Ltd (ZURA) - Forvard narx/daromad multiplikatori|aTyr (ATYR) - Narxning prognoz qilingan daromadga nisbati|ADAG (Adagene Inc.) - Narxning prognoz qilingan daromadga nisbati|IMA (ImageneBio) - Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati STTK (Shattuck Therapeutics)|Forvard narx/daromad multiplikatori EQ (Equillium, Inc.)|connectbiopharm.com - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Immunic IMUX|ATRA (Atara Biotherapeutics, Inc.) - Kelajakdagi narxning daromadga nisbati|InflaRx GmbH - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx XFOR (x4pharma.com)|ACET: Forvard P/S multiplikatori|Celularity (CELU) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati INmune Bio Corp|BRNS: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Kezar Life Sciences (KZR)|Forvard narx/daromad multiplikatori sabbiotherapeutics.com SABS|Forvard P/S multiplikatori AKTX (Akari Therapeutics Plc)|Forvard P/S multiplikatori Enlivex Therapeutics Ltd ENLV|QTTB: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx GOVX (GeoVax Corp)|EDSA: Forvard P/S multiplikatori|IBIO - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Carisma Therapeutics Inc|Forvard narx/daromad multiplikatori XTL Biopharmaceuticals Ltd (XTLB)|Narxning prognoz qilingan daromadga nisbati Bolt Biotherapeutics (BOLT)|Forvard narx/daromad multiplikatori hcwbiologics.com HCWB|Aptevo Therapeutics Inc. - Forvard narx/daromad multiplikatori|Forvard P/S multiplikatori AIM ImmunoTech, Inc. AIM|ADTX - Narxning prognoz qilingan daromadga nisbati|GRI (GRI Bio Inc) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|XRTX: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Vyome Therapeutics (HIND)|REVB (Revelation Biosciences) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori indaptusrx.com (INDP)|Forvard P/S multiplikatori SCNI|CALI - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Affimed N.V. AFMD|Allakos Inc - Narxning prognoz qilingan daromadga nisbati|HOOK - Narxning prognoz qilingan daromadga nisbati|IGMS: Narxning prognoz qilingan daromadga nisbati|ITOS: Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati OCEA|TCBP (TC BioPharm (Holdings) PLC) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Third Harmonic Bio Inc THRD
